Yifan Pharmaceutical Co., Ltd. (002019.SZ)

CNY 11.38

(0.53%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 11.49 Billion 12.54 Billion 12.16 Billion 11.63 Billion 11.06 Billion 9.77 Billion
Total Current Assets 3.25 Billion 3.68 Billion 3.58 Billion 3.5 Billion 3.52 Billion 3.69 Billion
Cash And Short Term Investments 773.37 Million 1.23 Billion 1.33 Billion 1.37 Billion 1.56 Billion 1.63 Billion
Cash and Cash Equivalents 698.36 Million 1.14 Billion 1.33 Billion 1.32 Billion 1.52 Billion 1.62 Billion
Short Term Investments 75.01 Million 95.5 Million -62.09 Million 46.73 Million 39 Million 10.08 Million
Net Receivables 1.39 Billion 1.52 Billion 1.39 Billion 1.34 Billion 1.23 Billion 1.36 Billion
Inventory 928.6 Million 830.97 Million 663.87 Million 583.85 Million 598.18 Million 477.83 Million
Other Current Assets 158.62 Million 92.4 Million 194.5 Million 203.36 Million 128.82 Million 219.64 Million
Total Non-Current Assets 8.24 Billion 8.85 Billion 8.57 Billion 8.13 Billion 7.54 Billion 6.07 Billion
Net PPE 1.81 Billion 1.6 Billion 1.64 Billion 1.45 Billion 1.24 Billion 1.07 Billion
Good Will And Intangible Assets 5.34 Billion 6.03 Billion 5.82 Billion 5.61 Billion 5.31 Billion 4.66 Billion
Good Will 2.73 Billion 2.73 Billion 2.73 Billion 2.74 Billion 2.72 Billion 2.64 Billion
Intangible Assets 2.6 Billion 3.29 Billion 3.09 Billion 2.86 Billion 2.58 Billion 2.01 Billion
Long-Term Investments 718.46 Million 601.18 Million 702.21 Million 619.5 Million 668.12 Million 33.65 Million
Tax Assets 257.81 Million 290.79 Million 244.37 Million 226.34 Million 163.61 Million 126.64 Million
Other Non Current Assets 117.35 Million 323.7 Million 161 Million 212.3 Million 162.12 Million 178.97 Million
Other Assets 1.00 1.00 - - - -
Total Liabilities 3.14 Billion 3.39 Billion 3.39 Billion 2.9 Billion 3.24 Billion 2.88 Billion
Total Current Liabilities 2.18 Billion 2.19 Billion 2.3 Billion 2.12 Billion 2.88 Billion 2.39 Billion
Account Payables 431.35 Million 288.4 Million 350.86 Million 381.18 Million 418.99 Million 416.96 Million
Tax Payables 19.13 Million 107.46 Million 82.56 Million 77.96 Million 115.25 Million 130.94 Million
Short Term Debt 1.11 Billion 1.23 Billion 1.43 Billion 1.21 Billion 1.82 Billion 1.46 Billion
Deferred Revenue 133.23 Million 203.26 Million 504.61 Million 523.5 Million 568.43 Million 130.94 Million
Other Current Liabilities 506.35 Million 476.49 Million 7.46 Million 13 Million 69.12 Million 383.98 Million
Total Non Current Liabilities 957.57 Million 1.19 Billion 1.08 Billion 778.06 Million 360.77 Million 490.97 Million
Long-Term Debt 812.04 Million 930.86 Million 820.3 Million 447.62 Million 83.96 Million 32.19 Million
Deferred Revenue Non Current 99.74 Million 104.84 Million 85.71 Million 80.32 Million 43.47 Million 29.17 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -8.73 Million 21.38 Million 34.42 Million 24.97 Million 21.35 Million 225.5 Million
Other Liabilities 1.00 - - 1.00 1.00 -
Total Equity 8.25 Billion 9.14 Billion 8.77 Billion 8.73 Billion 7.82 Billion 6.88 Billion
Stock Holders Equity 8.27 Billion 8.81 Billion 8.53 Billion 8.43 Billion 7.49 Billion 6.62 Billion
Common Stock 1.04 Billion 1.04 Billion 1.05 Billion 1.05 Billion 1.05 Billion 1.02 Billion
Retained Earnings 4.2 Billion 4.75 Billion 4.56 Billion 4.35 Billion 3.5 Billion 2.74 Billion
Accumulated other comprehensive income 200.87 Million 27.2 Million 76.38 Million 184.63 Million 74.46 Million 166.18 Million
Common Stock Equity 8.27 Billion 8.81 Billion 8.53 Billion 8.43 Billion 7.49 Billion 6.62 Billion
Capital Lease Obligation 66.72 Million 80.69 Million 89.79 Million 72.64 Million 1.2 Million 1.65 Million
Total Investments 793.47 Million 696.68 Million 640.12 Million 666.23 Million 707.12 Million 43.74 Million
Total Debt 1.99 Billion 2.16 Billion 2.25 Billion 1.65 Billion 1.91 Billion 1.49 Billion
Net Debt 1.29 Billion 1.01 Billion 923.05 Million 335.09 Million 387.06 Million -130.76 Million

Balance Sheet Charts